Caris Life Sciences, Inc. (CAI)
26.03
-7.19
(-21.64%)
USD |
NASDAQ |
Nov 05, 16:00
26.20
+0.17
(+0.65%)
After-Hours: 20:00
Caris Life Sciences Free Cash Flow : 21.20M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 21.20M |
| June 30, 2026 | 116.25M |
| March 31, 2026 | 115.75M |
| December 31, 2025 | 59.18M |
| Date | Value |
|---|---|
| September 30, 2025 | -14.01M |
| June 30, 2025 | -140.59M |
| March 31, 2025 | -212.01M |
| December 31, 2024 | -253.64M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Natera, Inc. | 51.20M |
| Myriad Genetics, Inc. | -19.90M |
| BioRestorative Therapies, Inc. | -11.90M |
| CareDx, Inc. | 59.76M |
| Exagen, Inc. | -7.588M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.25M |
| Cash from Investing (Quarterly) | -17.47M |
| Cash from Financing (Quarterly) | 14.23M |
| Free Cash Flow Per Share (Quarterly) | -0.1346 |
| Free Cash Flow to Equity (Quarterly) | -50.33M |
| Free Cash Flow to Firm (Quarterly) | -31.36M |
| Free Cash Flow Yield | 0.28% |